AlbertoBroniscerMD

Clinical Trials

• Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma Start of enrollment: 2005 Mar 01

  Completed

  Phase 1, Phase 2

• Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma Start of enrollment: 2007 Apr 01

  Completed

  Phase 1

• Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25

  Completed

  Phase 1

• DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma Start of enrollment: 2006 Jun 01

  Completed

• Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) Start of enrollment: 2009 Oct 01

  Completed

  Phase 1

• Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19

  Active, not recruiting

  Phase 1, Phase 2

• PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Start of enrollment: 2011 Jul 01

  Completed

  Phase 1

• Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG) Start of enrollment: 2012 Nov 27

  Completed

  Phase 1

• Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Start of enrollment: 2014 Apr 01

  Terminated

  Phase 2

• p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Start of enrollment: 2013 Aug 01

  Completed

  Phase 1

• Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Start of enrollment: 2014 May 14

  Active, not recruiting

  Phase 2

• Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
• A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17

  Recruiting

  Phase 1, Phase 2

  Roles: Contact, Principal Investigator

• Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Start of enrollment: 2019 Jul 25

  Suspended

  Phase 1, Phase 2

  Roles: Contact

• Join now to see all